Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Insurance type linked to cancer care delays

Wharam et al. J Clin Oncol. 2018 Feb 28. doi: 10.1200/JCO.2017.75.2501.

Key clinical point: Many women have high-deductible health plans that may discourage them from seeking essential care when needed.

Major finding: Women with an employer-mandated switch from a low- to high-deductible health plan had significant delays in diagnostic imaging, biopsy, diagnosis, and cancer care.

Study details: Controlled pre-post study of data on 273,499 women and 2.4 million controls.

Disclosures: The study was supported by National Cancer Institute and National Institute of Health grants. Dr. Wharam and three coauthors reported no conflicts of interest. Three coauthors reported honoraria and/or consulting/advisory roles with various companies.

Source: Wharam et al. J Clin Oncol. 2018 Feb 28. doi: 10.1200/JCO.2017.75.2501.

Read the article.

Citation:

Wharam et al. J Clin Oncol. 2018 Feb 28. doi: 10.1200/JCO.2017.75.2501.